Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzymatic dynamic kinetic resolution for high-purity (R)-praziquantel. Reduces cost and improves supply chain reliability for API manufacturing.
Novel CvFAP mutant enables high-purity L-glufosinate synthesis via blue light catalysis, offering significant cost and supply chain advantages for herbicide manufacturers.
Advanced biocatalytic dynamic kinetic resolution patent CN103820521B enables high-purity pharmaceutical intermediate manufacturing with substantial cost reduction and supply reliability.
Patent CN1322200A details a scalable enantioselective synthesis for non-steroidal antiestrogen intermediates. Discover cost reduction in pharmaceutical manufacturing and supply chain advantages.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN110467539B reveals a cost-effective dynamic kinetic resolution for 2,6-dimethyl-L-tyrosine, eliminating noble metals and enhancing supply chain stability for peptide manufacturers.
Patent CN104151352B reveals a high-purity Sofosbuvir intermediate method. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN104152527B details a novel DKR method for R-2-naphthylethylamine. Achieve high yield and optical purity with cost-effective Raney nickel catalysts for scalable supply.
Patent CN100463903C reveals a novel hydrolase method for producing high-purity (S)-indoline-2-carboxylic acid, offering significant cost reduction in API manufacturing.
Novel enzymatic resolution process ensures high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains globally. This patent offers significant advantages.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN113249417B reveals a biocatalytic route for chiral cis-beta-aryl-beta-hydroxy-alpha-amino esters using KRED-Bt, offering high stereoselectivity and industrial scalability.
Patent CN104263803B enables high-purity S-2-tetrahydronaphthalene amines production with superior yield and optical purity for reliable pharmaceutical intermediates supply chains.
Patent CN105063164A reveals DKR method for S-6-Methoxy-1-Aminoindane. High purity and yield offer supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN105154513A analysis reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN105063163A reveals enzyme-catalyzed DKR for high-purity chiral intermediates. Offers cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN105154514A enables high-purity (S)-5-methyl-1-aminoindane via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN104263803A details high-purity S-2-tetrahydronaphthalene amine synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104263799A enables high-purity S-2-tetrahydronaphthylamine via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN102728407B details a waste-utilizing synthesis for chiral salen catalysts, offering cost reduction in pharmaceutical intermediate manufacturing via single-solvent processes.